Malignant epithelioid mesothelioma
MONDO:0005599A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic cells with an epithelioid appearance. In the majority of cases, the neoplastic epithelioid cells lack significant cytologic atypia; mitotic figures are infrequently seen. In a minority of cases, the neoplastic cells are poorly differentiated and there is evidence of nuclear atypia and increased mitotic activity.
Also known as: epithelial mesothelioma, epithelioid mesothelioma, epithelioid mesothelioma, malignant, epithelioid mesothelioma, malignant (morphologic abnormality), malignant epithelial mesothelioma
2741 clinical trials for this condition and its sub-types, 5 tagged with Malignant epithelioid mesothelioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Malignant epithelioid mesothelioma
-
Pleural epithelioid mesothelioma 8 trials
-
Experimental CAR t therapy targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-stage study is testing a new treatment called SynKIR-110 for people with advanced ovarian cancer, bile duct cancer, or mesothelioma that has spread or come back. The treatment involves taking a patient's own immune cells, engineering them in a lab to better recognize a…
Phase 1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug CT-95 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called CT-95 in people with advanced cancers that have a protein called mesothelin on their cells. The main goals are to find a safe dose and see if the drug can shrink tumors. About 70 adults with ovarian, lung, pancreatic, or other mesoth…
Phase 1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC